• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.13% Nasdaq Down 0.93%

    Acorda Therapeutics, Inc. (ACOR)

    -NasdaqGS
    42.54 1.16(2.65%) Jan 28, 4:00PM EST
    |After Hours : 42.54 0.00 (0.00%) Jan 28, 4:38PM EST
    Add to Portfolio
    Prev Close:43.70
    Open:44.12
    Bid:42.00 x 1700
    Ask:N/A
    1y Target Est:45.08
    Beta:1.85
    Earnings Date:Feb 11 - Feb 16 (Est.)
    Day's Range:42.45 - 44.16
    52wk Range:28.26 - 45.45
    Volume:495,018
    Avg Vol (3m):525,358
    Market Cap:1.75B
    P/E (ttm):77.49
    EPS (ttm):0.55
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ACORDown 2.65%1.75B
    BIIB82.93B
    TEVA49.52B

    Key Statistics

    Forward P/E (1 yr):250.24
    P/S (ttm):4.79
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :0.50
    Quarterly EPS Est (Dec-14) :0.10
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):1.89

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback